Vinblastine for Leukoreduction in Newly Diagnosed AML and Hyperleukocytosis
Clinical trial NCT05062278 · UNKNOWN
Trial details
- NCT number
- NCT05062278
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2025-07-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.